 |
 |

Use of Intraoperative Parathyroid Hormone Measurement Does Not Improve Success of Bilateral Neck Exploration for Hyperparathyroidism
Frederic L. Starr, MD;
Robert DeCresce, MD;
Richard A. Prinz, MD
Arch Surg. 2001;136:536-542.
Hypothesis Use of intraoperative measurement of intact parathyroid hormone (iPTH) to confirm complete excision of hyperfunctioning parathyroid tissue does not improve overall operative success rates.
Design Case series of patients undergoing parathyroidectomy with or without intraoperative iPTH measurement.
Setting University teaching hospital.
Patients and Interventions Fifty patients undergoing parathyroidectomy before our institution of intraoperative iPTH sampling in March 1999 (group 1) were compared with 50 patients undergoing parathyroidectomy after this technique was adopted (group 2). Overall, 100 patients underwent operation between December 1996 and May 2000. Serum calcium and iPTH levels were measured at 1- and 3-month intervals. Intraoperative frozen sections and operative times were also analyzed.
Results Mean preoperative calcium levels were 2.85 and 2.82 mmol/L (11.4 and 11.3 mg/dL) in groups 1 and 2, respectively. One-month postoperative calcium values were identical in both groups at 2.35 mmol/L (9.4 mg/dL) (group 1 SD = 0.18 [0.74], group 2 SD = 0.20 [0.82]). At 1 month, all but 1 patient in group 1 had normalized calcium values (2% failure rate), while 3 patients in group 2 (6%) remained hypercalcemic. All 3 patients in group 2 had intraoperative iPTH levels that returned to normal. There was a significant difference in the number of intraoperative frozen sections between groups, with a mean (SD) of 3.4 (1.7) in group 1 and 2.0 (1.6) in group 2 (P<.01). There was no significant difference in operative times between groups.
Conclusions Use of intraoperative iPTH sampling did not significantly affect the overall success of parathyroidectomy, as determined by postoperative normocalcemia. There was, however, a significant decrease in the number of frozen sections sent at operation.
From the Departments of General Surgery (Drs Starr and Prinz) and Pathology (Dr DeCresce), Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill.
RELATED ARTICLE
This Month in Archives of Surgery
Arch Surg. 2001;136(5):498.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Intra-operative Parathyroid Hormone Monitoring in Patients with Parathyroid Cancer
Solorzano et al.
Ann. Surg. Oncol. 2007;14:3216-3222.
ABSTRACT
| FULL TEXT
Which Intraoperative Parathyroid Hormone Assay Criterion Best Predicts Operative Success?: A Study of 352 Consecutive Patients
Chiu et al.
Arch Surg 2006;141:483-488.
ABSTRACT
| FULL TEXT
Rapid Intraoperative Immunoassay of Parathyroid Hormone and Other Hormones: A New Paradigm for Point-of-Care Testing
Sokoll et al.
Clin. Chem. 2004;50:1126-1135.
ABSTRACT
| FULL TEXT
An Alternative Analysis of Intraoperative Parathyroid Hormone Data May Improve the Ability to Detect Multiglandular Disease
Gauger et al.
Arch Surg 2004;139:164-169.
ABSTRACT
| FULL TEXT
Pitfalls of Intraoperative Quick Parathyroid Hormone Monitoring and Gamma Probe Localization in Surgery for Primary Hyperparathyroidism
Jaskowiak et al.
Arch Surg 2002;137:659-669.
ABSTRACT
| FULL TEXT
Intraoperative Parathyroid Hormone Measurement in Patients With Secondary Hyperparathyroidism
Chou et al.
Arch Surg 2002;137:341-344.
ABSTRACT
| FULL TEXT
|